Diabetes Board decisions

The veteran withdrew his appeal regarding the initial evaluation for service-connected diabetes mellitus.

The Board denied the veteran's claims for service connection for hypertension, coronary artery disease, and diabetic nephropathy as secondary to his service-connected diabetes mellitus.

The Board denied the veteran's claims for service connection for low back disability, left knee disability, PTSD, diabetes mellitus, and low blood pressure with chronic dizziness and lightheadedness. The decision was based on a finding that new and material evidence had not been submitted to reopen these claims.

The Board found no evidence of exposure to Agent Orange during service, and thus could not grant presumptive service connection for type 2 diabetes mellitus or prostate cancer. The appellant's hypertension was also denied as it is not related to his service-connected conditions.

The veteran's income exceeded the maximum annual pension rates for improved pension benefits from 2001 to 2003. His claim for service connection for diabetes mellitus secondary to Agent Orange exposure is pending due to additional development required, and his claims for psychiatric disability are also pending.

The veteran's Type II diabetes mellitus is presumed to be due to herbicide exposure in service. The Board also found that the veteran's hypertension and pancreatitis are related to his service-connected diabetes.

The Board has determined that the veteran did not have service in Vietnam and was not exposed to Agent Orange. Therefore, his claims for secondary service connection are denied.

The Board has determined that the evidence is in equipoise, warranting a full grant of service connection for the cause of the veteran's death due to diabetes mellitus.

The Board found that the veteran's diabetes mellitus did not have its onset during service or within one year of discharge, and there is no evidence linking it to a service-connected condition. The Board also determined that the veteran's PTSD did not cause or chronically worsen his diabetes mellitus.

The Board found no evidence linking the veteran's hypertension to service or any incident therein. The onset of his diabetes preceded that of his hypertension, and there is no competent medical evidence showing a link between the two conditions. Therefore, the claim for secondary service connection for hypertension was denied.

The veteran's Type 2 diabetes mellitus has required insulin use, a restricted diet, and regulation of activities since March 20, 2002. The Board granted a 40 percent evaluation for this condition.

The Board denied the veteran's claim for service connection for diabetes mellitus, finding that it was not manifested during active duty or within one year of separation from active duty and is not related to service.

The veteran's diabetes mellitus is currently rated at 60 percent disabling, which meets the criteria for a complete grant of benefits.

The Board found that the veteran's hypertension is not related to his active service, including presumed in-service herbicide exposure. The PTSD claim was also denied as there is no evidence of a nexus between the disability and service.

The Board found that the veteran does not have diabetes mellitus, type II and denied service connection for bilateral hearing loss. The effective date remains unchanged.

The Board denied a higher initial evaluation for diabetes mellitus associated with herbicide exposure, currently rated at 20 percent.

The veteran's claims for service connection for various conditions, including PTSD, low back disorder, diabetes mellitus, hypertension, flatfeet, skin disorder, headaches, nosebleeds, sleep apnea, joint pain, depression with memory loss, sexual dysfunction, and neuropathy of the upper and lower extremities, were denied as there is no competent medical evidence linking these conditions to service or any incident during service.

The veteran's claims for service connection for various conditions, including tinnitus, diabetic retinopathy, peripheral neuropathy of the upper and lower extremities, polyuria, gastric esophageal reflux disease, and hypertension, were denied. The Board found that there was no evidence to support these claims.

The Board found that the veteran's death was due to pancreatitis, Type I diabetes and anoxic encephalopathy. These conditions were not present in service or related to service, including exposure to herbicides.

The Board denied the veteran's claims for service connection for diabetes, finding that there was no exposure to Agent Orange and insufficient evidence linking the condition to his service.